Aileron Therapeutics, Inc.ALRNNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-65.11M
↓ 139% below average
Average (9y)
$-27.21M
Historical baseline
Range
High:$-12.89M
Low:$-65.11M
CAGR
+19.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-65.11M | -300.0% |
| 2023 | $-16.28M | +41.1% |
| 2022 | $-27.65M | -3.9% |
| 2021 | $-26.61M | -29.8% |
| 2020 | $-20.50M | +31.6% |
| 2019 | $-29.96M | +6.1% |
| 2018 | $-31.90M | -38.7% |
| 2017 | $-23.01M | -26.6% |
| 2016 | $-18.17M | -40.9% |
| 2015 | $-12.89M | - |